In cancer, DNA methylation changes are common and can affect the expression of tumor suppressor genes and oncogenes. Hypermethylation of promoter regions can lead to the silencing of genes that normally prevent cancer, while hypomethylation can activate genes that promote cell growth and division. Understanding these methylation changes can help identify biomarkers for early cancer detection, predict patient prognosis, and guide therapy decisions.
